A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency
Public ClinicalTrials.gov record NCT03311269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Controlled, Multi-Center, Double Blind Study of ClariVein RES for Treatment of Venous Insufficiency Associated With Incompetent Saphenous Veins Due to Superficial Venous Reflux
Study identification
- NCT ID
- NCT03311269
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vascular Insights, LLC
- Industry
- Enrollment
- 19 participants
Conditions and interventions
Conditions
Interventions
- ClariVein RES Device
- Sodium Tetradecyl Sulfate 1% Injection Drug
- Sodium Tetradecyl Sulfate 3% Injection Drug
Device · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 21, 2017
- Primary completion
- May 14, 2018
- Completion
- Mar 26, 2020
- Last update posted
- Mar 1, 2022
2017 – 2020
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Vascular Experts | Darien | Connecticut | 06820 | — |
| Capitol Vein and Laser Centers | Frederick | Maryland | 21702 | — |
| Southeastern Surgical Associates | Hyannis | Massachusetts | 02601 | — |
| Englegwood Hospital and Medical Center | Englewood | New Jersey | 07631 | — |
| Lake Washington Vascular, PLLC | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03311269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03311269 live on ClinicalTrials.gov.